by Tom Cox on August 6, 2013
Below are ten of the last month’s best intellectual property law blogs and news posts from around the web:- A Collection of Copyright Carry Ons with the CopyKat (The 1709 Blog) The 1709 Blog offers a whistle-stop tour from around the world of copyright over the last month. From copyright reform in China to dentists […]
by VolpeKoenig on March 21, 2013
As reviewed in Part 1 of this post, inventors should be aware of similarities and differences in what constitutes patentable biotech subject matter in the U.S. and Europe. This post discusses the nuances of patenting biotech inventions in Europe and identifies biotech products that are patentable. Part 2. Europe In Europe, patentability is governed by Article 52 […]
by VolpeKoenig on March 20, 2013
The United States and Europe are the main jurisdictions where inventors in the field of biotechnology are seeking patent protection. They should be aware of similarities and differences in what constitutes patentable subject matter in the U.S. and Europe. In Part One of this post, we will explore patent protection for biotechnology in the United […]
by VolpeKoenig on February 26, 2013
In December 2012, the European Parliament and Member States reached a long-awaited agreement approving a unitary European patent. The European Parliament approved two European Union (EU) regulations, one creating a European patent with unitary effect (or “unitary patent”) and the other creating a multinational Unified Patent Court (UPC). Before it can become effective, at least […]
by VolpeKoenig on February 5, 2013
Recent developments in the case law have expanded induced infringement to include performance of the method claims steps by multiple actors. See Value Added to Medical Method and Diagnostic Patents through Induced Divided Infringement. The change comes from the Federal Circuit in Akamai Tech. v. Limelight Networks and may impact how claim drafters formulate method claims. It will […]
by MsShipp on January 14, 2013
What if you were approached by a stranger who claimed to be a business mogul, and he told you that he could offer you an opportunity to invest just a little bit of your money and double or triple it within weeks or even days? At first, you might be skeptical, but what if he […]
by IP Blawg on May 22, 2012
Charles is a solicitor and works with clients on cases pertaining to industrial disease compensation. In his spare time he enjoys writing about patent disputes and infringement claims. As of October 2011, Samsung and Apple had nine patent disputes underway in courts all over the world. Among the claims by Apple is one that Samsung […]